About Briogem Pharma Private Limited
Data last updated:
Briogem Pharma Private Limited is a private limited company based in Guwahati, Assam, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 February 2020.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U51909AS2020PTC019948.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Niranjan Deka and Eti Deka.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Bandana Medhi R.K. Choudhury Road Arunodoy Path Santipur Swicegate, Guwahati, Assam, India – 781009.
The last known website on record is briogembiogenics.com.
Company details
Contact details
Briogem Pharma Private Limited's registered office is in Guwahati, Assam. Its website is briogembiogenics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressC/O Bandana Medhi R.K. Choudhury Road Arunodoy Path Santipur Swicegate, Guwahati, Assam, India – 781009
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Briogem Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Briogem Pharma Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Briogem Pharma Private Limited, buy the company report.
Board of directors of Briogem Pharma Private Limited
Briogem Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Niranjan Deka | Director | 27 Feb 2020 | 6 Years 8 Months | Current |
| Eti Deka | Director | 27 Feb 2020 | 6 Years 8 Months | Current |
Auditor
Briogem Pharma Private Limited is audited by AYUSH SARAF & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AYUSH SARAF & ASSOCIATES | FY 2023 | 327819E |
Shareholding
The shareholding of Briogem Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Briogem Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Briogem Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Briogem Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Briogem Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Briogem Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Eti Deka was appointed as Director on 27 Feb 2020.
Frequently asked questions
Briogem Pharma is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Briogem Pharma is a company pending strike off, currently registered as a private limited company based in Guwahati, Assam, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 February 2020 and is registered under CIN U51909AS2020PTC019948. The company may be struck off soon - caution is advised.
Briogem Pharma has 2 current directors:
- Niranjan Deka - Director
- Eti Deka - Director
The CIN (Corporate Identification Number) of Briogem Pharma is U51909AS2020PTC019948. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Briogem Pharma was incorporated on 27 February 2020. It is registered with the Registrar of Companies, Guwahati.
Briogem Pharma can be reached through the website briogembiogenics.com. Its registered office is in Guwahati, Assam, India.
The registered office of Briogem Pharma is at CO Bandana Medhi R.K. Choudhury Road Arunodoy Path Santipur Swicegate, Guwahati, Assam, India – 781009.
The latest financial statements of Briogem Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
Briogem Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Eti Deka was appointed as Director on 27 Feb 2020. Niranjan Deka was appointed as Director on 27 Feb 2020.